Corindus Vascular Robotics (Formerly known as Corindus) Release: Published Robotic PCI Study Reveals Favorable Results With Respect To Patient Radiation Exposure, Fluoroscopy Time, And Contrast Volume

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, the leader in precision vascular robotics, today announced that the Journal of Invasive Cardiology published the results of a retrospective study comparing use of radiation and contrast for patients enrolled in its CorPath® PRECISE (Percutaneous Robotic-Enhanced Coronary Intervention) study to a matched traditional manual PCI patient in the July 2014 issue (Vol. 26, Issue 7, 2014). Results of the study demonstrate the CorPath System provides significantly lower harmful radiation exposure to the patient when CorPath is used for the complete intervention.

Help employers find you! Check out all the jobs and post your resume

MORE ON THIS TOPIC